Integrated nuclear proteomics and transcriptomics identifies S100A4 as a therapeutic target in acute myeloid leukemia. (2020)
Attributed to:
Manchester Academic Health Science Centre Technology Hub: Clinical Proteomics Centre for Stratified Medicine
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1038/s41375-019-0596-4
PubMed Identifier: 31611628
Publication URI: http://europepmc.org/abstract/MED/31611628
Type: Journal Article/Review
Volume: 34
Parent Publication: Leukemia
Issue: 2
ISSN: 0887-6924